CRP and hydrops fetalis: Prognostic significance of CRP for HF and its outcome was demonstrated in various clinical settings [25,37,42,43,44,45]; however, data on CRP as a risk marker for HF over a long-term follow-up in STEMI patients undergoing guideline-based therapies remain limited.